Certified by Founder
Lodge
Biorithm
start up
Singapore
- Singapore
- 19/12/2023
- Series A
- $3,500,000
By leading a new standard of maternity care, Biorithm aims to end preventable pregnancy complications & stillbirth through predictive and precision medicine.
Forging new frontiers in women's health and pregnancy care to improve outcomes globally, we have developed cutting-edge analytic software together with medical-grade wearables for accurate monitoring of a wide range of pregnancy data.
Founded by doctors & engineers, Biorithm is a medical technology company, spun off from Nanyang Technological University Singapore (NTU).
- Industry Medical Device
- Website https://www.bio-rithm.com/
- LinkedIn https://www.linkedin.com/company/biorithm/about/
Related People
Amrish NairFounder
Singapore -
Singapore
Signal processing engineer with a focus on sparse sampling and biomedical applications. Experience with academia and interdisciplinary research with clinicians.
Project Eleven | $20,000,000 | (Jan 16, 2026)
CYB3R OPERATIONS | $5,400,000 | (Jan 16, 2026)
Quadric | $30,000,000 | (Jan 16, 2026)
GovDash | $30,000,000 | (Jan 16, 2026)
RouteSense | $2,000,000 | (Jan 16, 2026)
Vista AI | $29,500,000 | (Jan 16, 2026)
depthfirst | $40,000,000 | (Jan 16, 2026)
Slips | $3,500,000 | (Jan 16, 2026)
FOVC | $2,000,000 | (Jan 16, 2026)
VoiceRun | $5,500,000 | (Jan 16, 2026)
Emversity | $30,000,000 | (Jan 16, 2026)
Pinch AI | $5,000,000 | (Jan 16, 2026)